Evogene Reports Second Quarter 2022 Financial Results
August 31, 2022
Ryan Allway August 31st, 2022 News, Top News Conference call and webcast: today, August 31, 2022, 9:00 am ET REHOVOT, Israel, Aug. 31, 2022 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today its financial results... Read more
Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program
November 30, 2021
Earlier this year, initial positive pre-clinical results pointing to reduction of inflammation following treatment with BMC321 and BMC322, were achieved using a DSS-induced colitis mouse model. These results were presented at the 2021 Crohn’s & Colitis Congress, jointly organized by the American Crohn’s & Colitis Foundation (CCFA) and the... Read more
